Recent Activities - 2020

Head-to-head Comparison of Antibody Detection Assays for SARS-CoV-2

30 Oct 2020

NRL is pleased to announce an agreement with the WHO Emergency Use Group to conduct a comprehensive evaluation of COVID19 serology test kits designed to detect antibodies to SARS-CoV-2 virus.  Since the onset of the pandemic, hundreds of serology test kits otherwise referred to as in-vitro diagnostic devices (IVDs) have been released for use without manufacturers being required to undergo formal conformity assessment and provide comprehensive evidence of performance characteristics of the IVD. 

NRL to Develop Guidelines for the Design and Implementation of Post-Market Monitoring of Near Patient In-Vitro Diagnostic Devices

30 Oct 2020

NRL is developing and finalizing guidance for end-users on how to conduct quality monitoring of in-vitro diagnostics (IVDs) and to develop use cases for better supply of end-user quality control materials and proficiency testing panels.  In association with the WHO Regulation and Safety (REG)/Incidents and Substandard/Falsified Medical Products (ISF) group, NRL will develop guidelines that will inform Global Fund and other procurers of near-patient testing IVDs on how to establish a quality assurance and post market framework. 

NRL Supporting the South East Asia Laboratory Strengthening Project

30 Oct 2020

The South East Asia Laboratory Strengthening (SEALAB) project aims to reinforce national health systems in Cambodia, Laos and Myanmar through strengthening laboratory capacity to detect and respond to infectious disease outbreaks of a potentially pandemic nature.  Funded by the Indo-Pacific Centre for Health Security at the Department of Foreign Affairs and Trade (DFAT), Australia, and in collaboration with the SEALAB lead organization, the Mérieux Foundation, and Integrated Quality Laboratory Services (IQLS), NRL’s role is to support and strengthen the quality of testing being performed. This activity has commenced in the following countries:

IAEA and WHO-WPRO Webinar Series to Support the COVID-19 Testing Laboratories in the Asia and the Pacific Region

30 Sep 2020

The COVID-19 global pandemic has presented major challenges in public health sectors worldwide. As part of the UN Crisis Management Team (CMT), the IAEA and WHO are working together towards strengthening public health, supply of essential equipment, training, and investment in laboratory systems of Member States to address challenges posed by COVID-19 pandemic.

NRL Welcomes New Staff Member Francois Lamoury to the Scientific Consulting and Training Team

01 Sep 2020

We are excited to announce that in September, Francois Lamoury joined NRL as a Senior Scientist in the Scientific Consulting and Training team. Francois has more than 25 years’ experience in medical and clinical laboratory research, has an Engineering degree in biotechnology from the Conservatoire National des Arts et Métiers, Paris, France, and a MBA from AGSM, UNSW Sydney. . Prior to NRL, Francois worked at the Foundation for Innovative New Diagnostics (FIND) on the validation of new diagnostics tools in low- and middle- income countries for the detection of Hepatitis C virus (HCV).

NRL Scientific Consulting and Training: NRL Supports the South East Asia Laboratory Strengthening Project

07 Aug 2020

NRL, along with Integrated Quality Laboratory Services, are part of a Consortium led by the Mérieux Foundation authorised to reinforce national health systems in Cambodia, Laos and Myanmar.  The South East Asia Laboratory Strengthening (SEALAB) project leverages upon the One Health approach to support and strengthen human and animal health laboratory capacity to detect and respond to emerging infectious disease outbreaks which are potentially pandemic and/or zoonotic threats. 

NRL Scientific Consulting and Training: NRL Contributes to the Strengthening of HIV Testing in Myanmar

29 Jul 2020

With funding from the U.S. President's Emergency Plan for AIDS Relief, and through a cooperative agreement between ICAP at Columbia University (ICAP) and the US Centers for Disease Control and Prevention (CDC), NRL is supporting the Myanmar Ministry of Health and Sports to develop, implement, and monitor the provision of high-quality HIV testing services, to achieve the 95-95-95 targets amongst all populations by 2030.  As part of these efforts, NRL staff member Sandy Walker conducted two virtual training programs for approximately 90 participants from the National Health Laboratory (NHL), the National AIDS Program (NAP), and 17 state and regional hospitals.  The first training session was held from 29 to 30 July, and covered the theory on HIV Confirmatory Testing in Myanmar.

NRL Scientific Consulting and Training: Supporting HIV Testing in Myanmar

01 Apr 2020

Myanmar continues to strive towards the development and sustainability of effective and high quality laboratory systems, to support progress towards 90-90-90 targets by 2020, as a milestone for further achievement of 95-95-95 targets by 2030.

NRL Joins Victorian COVID-19 Response

05 Mar 2020

NRL, a division of the St Vincent’s Institute of Medical Research, has joined the Burnet and Doherty Institutes in supporting the Victorian State Government response to COVID-19, focusing on the development of new diagnostic technologies, clinical research and strengthening the public health response.  Funded by Victorian State Government $6 million funding pool, NRL will develop a biorepository of well-characterised samples as well as antibody reference and confirmatory tests to evaluate new diagnostic assays, including rapid point of care tests, as they become available.

ACH2 Grant Awarded for the Validation of VL-PlasmaA® Device for use in HTLV Proviral Load and Antibody Testing

28 Feb 2020

NRL Principal Scientist A/Prof Rosemary Ffrench and collaborators from the Burnet, Baker and Peter Doherty Institutes were successful in their application for an ACH2 grant for the: Validation of VL-Plasma® device for use in HTLV proviral load and antibody testing. This study, which commenced in January 2020, will use the VL-Plasma device developed by A/Prof David Anderson and his team at the Global Health Diagnostic Development Laboratory at the Burnet Institute

NRL bids farewell to Dr Thein Thein Aye

30 Jan 2020

It was with great sadness that we said farewell in January to Dr Thein Thein Aye after more than twenty years as a loyal and longstanding member of staff. We took the opportunity to celebrate her contribution and welcomed NRL’s previous Directors Dr Liz Dax and Sue Best and other former NRL staff to join us for the occasion. We celebrated Thein Thein’s generous spirit and her can-do attitude and recognised the selfless service and the strong commitment she has demonstrated to the mission of NRL.

NRL Supports HIV Testing in Myanmar

30 Nov 2020

From October 2019 to September 2020, NRL has continued to support the Myanmar Ministry of Health and Sports in the provision of high-quality HIV testing services, aimed at achieving 95-95-95 targets amongst all populations by 2030.  Funded by the U.S. President's Emergency Plan for AIDS Relief, through a cooperative agreement between ICAP at Columbia University (ICAP) and the US Centers for Disease Control and Prevention (CDC), the support provided by NRL has included the development of a number of Protocols and guidance documents regarding HIV testing.

Contact Us

 Address: 4th Floor, Healy BuildinNRL

4th Floor, Healy Building

41 Victoria Parade

Fitzroy VIC 3065

Australia

Fax: +61 3 9418 1155

Phone: +61 3 9418 1111

Email: info@nrlquality.org.au

Social Media

  • Twitter Social Icon
  • LinkedIn Social Icon

NRL is designated a WHO Collaborating Centre for Diagnostics and Laboratory Support for HIV and AIDS and Other Blood-borne Infections